GenomeMe
IHC monoclonal antibodies
GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since their inception in 2017, their goal has been to develop each of the 260+ clinical IHC antibodies in-house, making them the first and only institution to date to achieve this.
Because GenomeMe develops and manufactures all antibodies in-house, they are able to offer distributors, OEM partners, and end user customers the best value and quality. GenomeMe Lab Inc. is rising to be a dominant player in diagnostic IHC applications, an increasingly essential part of future precision medicine technologies.
GenomeMe's catalog comprises of over 260+ IHC monoclonal antibodies for popular and unique markers.
EastMabBio
High-Quality Recombinant Proteins
Vitro Biopharma
Biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune di...
Norgen Biotek
Sample collection, storage, and isolation of high-purity nucleic acids
in-EV
Extracellular Vesicles
KactusBio
Active recombinant proteins and enzymes